| [1] |
Liefaard LC, Ploeger BA, Molthoff CF, et al. Changes in GABAA receptor properties in amygdala kindled animals:In vivo studies using[11C]flumazenil and positron emission tomography. Epilepsia, 2009, 50(1):88-98. Epub 2008 Aug 25.
|
| [2] |
Marini C, Harkin LA, Wallace RH, et al. Childhood absence epilepsy and febrile seizures:a family with a GABA (A) receptor mutation. Brain, 2003, 126(pt 1):230-240.
|
| [3] |
Fedi M, Berkovic SF, Marini C, et al. A GABAA receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding. Neuroimage, 2006, 32(3):995-1000.
|
| [4] |
Zimmerman G, Njunting M, Ivens S, et al. Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats. Eur J Neurosci, 2008, 27(4):965-975.
|
| [5] |
Lipovsek M, Plazas P, Savino J, et al. Properties of mutated murine alphagbeta2 nicotinic receptors linked to partial epilepsy. Neurosci Lett, 2008, 434(2):165-169.
|
| [6] |
Mohamed A, Eberl S, Fulham M J, et al. Sequential 123I-iododexetimde scans in temporal lobe epilepsy:comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging). Eur J Nucl Med Mol Imaging, 2005, 32(2):180-185.
|
| [7] |
Picard F, Bruel D, Servent D, et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients:a PET study. Brain, 2006, 129(Pt 8):2047-2060.
|
| [8] |
Yu M, Tueckmantel W, Wang X, et al. Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine:synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors. Nucl Med Biol, 2005, 32(6):631-640.
|
| [9] |
Severance AJ, Parsey RV, Kumar JS, et al. In vitro and in vivo evaluation of[11C]MPEPy as a potential PET ligand for mGlu5 receptors. Nucl Med Biol, 2006, 33(8):1021-1027.
|
| [10] |
Bankstahl JP, Hoffmann K, Bethmann K, et al. Glutamate is critically involved in seizure-induced overexpression of Pglycoprotein in the brain. Neuropharmacology, 2008, 54(6):1006-1016.
|
| [11] |
Surmeier DJ, Ding J, Day M, et al. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci, 2007, 30(5):228-235.
|
| [12] |
Fedi M, Berkovic SF, Scheffer IE, et al. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy. Neurology, 2008, 71(11):795-798.
|
| [13] |
Frost JJ. Receptor localization and quantification with PET. Radiology, 1988, 169(1):273-274.
|
| [14] |
Hammers A, Asselin MC, Hinz R, et al. Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain, 2007, 130(Pt 4):1009-1016.
|